UNRESECTABLE UROTHELIAL CARCINOMA
Clinical trials for UNRESECTABLE UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail of drugs tested for tough bladder cancer
Disease control OngoingThis early-phase trial tests a combination of three drugs (tremelimumab, durvalumab, and belinostat) in people with advanced bladder cancer that has spread or cannot be removed surgically. The main goal is to find the safest dose and understand side effects. About 9 adults who ha…
Matched conditions: UNRESECTABLE UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: University of Utah • Aim: Disease control
Last updated May 17, 2026 03:12 UTC
-
New drug combo targets tough cancers in early trial
Disease control OngoingThis early-phase trial tests a new drug (BAY 1895344) combined with standard chemotherapy in people with advanced solid tumors, especially bladder cancer. The goal is to find the safest dose and see how well the combination works. About 74 adults with cancers like lung, bladder, …
Matched conditions: UNRESECTABLE UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Can a gene test tell who will respond to immunotherapy?
Knowledge-focused OngoingThis study looks at whether certain genetic changes in tumors can help predict if the immunotherapy drug nivolumab will work for people with advanced bladder cancer that has spread. Researchers are testing tumor samples for specific gene mutations and a protein called CXCL13. The…
Matched conditions: UNRESECTABLE UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 03:00 UTC